Related Experiment Video
Updated: Jun 25, 2025
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Advances in Studying Cancer Immunology in Mice
1Departments of Dermatology, Pathology, and Immunobiology, Yale University, New Haven, Connecticut 06520, USA marcus.bosenberg@yale.edu.
Abstract:
The recent rise in effective immuno-oncology therapies has increased demand for experimental approaches to model anticancer immunity. A variety of mouse models have been developed and used to study cancer immunology. These include mutagen-induced, genetically engineered, syngeneic, and other models of cancer immunology. These models each have the potential to define mechanistic aspects of anticancer immune responses, identify potential therapeutic targets, and serve as preclinical models for further therapeutic development. Specific benefits and liabilities are characteristic of particular cancer immunology modeling approaches. The optimal choice and utilization of models depends on the cancer immunology scientific question being addressed and can serve to increase mechanistic understanding and development of human immuno-oncology therapies.
Insights
Developing effective immuno-oncology therapies requires robust experimental models. This study reviews various mouse models for studying anticancer immunity, highlighting their benefits and limitations for advancing cancer immunology research.
Area of Science:
- Immunology
- Oncology
- Preclinical Research
Background:
- The success of immuno-oncology therapies has driven demand for better experimental models.
- Understanding anticancer immunity is crucial for developing new treatments.
Purpose of the Study:
- To review and compare different mouse models used in cancer immunology research.
- To discuss the advantages and disadvantages of various modeling approaches.
- To guide the selection of appropriate models for specific research questions.
Main Methods:
- Review of existing literature on mouse models for cancer immunology.
- Categorization of models including mutagen-induced, genetically engineered, and syngeneic models.
- Analysis of the utility of each model type for mechanistic studies and therapeutic development.
Main Results:
- Various mouse models offer distinct advantages for studying anticancer immunity.
- Each model type has specific benefits and limitations impacting their application.
- Model selection is critical for addressing specific scientific questions in cancer immunology.
Conclusions:
- Appropriate selection and use of mouse models are essential for advancing mechanistic understanding.
- Optimized modeling approaches can accelerate the development of human immuno-oncology therapies.
- Continued development and refinement of cancer immunology models are needed.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:27Tumor Immunotherapy